SCHEMBL1033710

SCHEMBL1033710

CCCC(=O)c1ccc(C(F)(F)F)cc1F

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.51
PDE2A O00408 2/20 0.46
KDM4E B2RXH2 3/20 0.45
HTT P42858 1/20 0.45
RXFP1 Q9HBX9 1/20 0.45
CES2 O00748 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
ALDH1A1 P00352 3/20 0.42
HPGD P15428 3/20 0.42
HSD17B10 Q99714 3/20 0.42
ALOX15 P16050 1/20 0.42
TSHR P16473 1/20 0.42
RECQL P46063 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
GSK3B P49841 1/20 0.42
CFTR P13569 1/20 0.42
CYP11B1 P15538 1/20 0.41
CYP11B2 P19099 1/20 0.41
NTRK1 P04629 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1031037 0.91 GAA (0.52) GAAPDE2AKDM4EHTTRXFP1
SCHEMBL2075208 0.87 GAA (0.54) GAAPDE2AKDM4EHTTRXFP1
SCHEMBL8369756 0.81 GAA (0.51) GAAPDE2AKDM4EHTTRXFP1
SCHEMBL1960700 0.80 PTPN1 (0.56) GAAPDE2AKDM4EHTTRXFP1
SCHEMBL30634441 0.80 PTPN1 (0.56) GAAPDE2AKDM4EHTTRXFP1
SCHEMBL18758206 0.80 GAA (0.50) GAAPDE2AKDM4EHTTRXFP1
SCHEMBL6944180 0.80 CES2 (0.57) CES2ALDH1A1HPGDHSD17B10ALOX15
SCHEMBL1036287 0.79 GAA (0.54) GAAPDE2AKDM4EHTTRXFP1
Hydrochloric Acid SCHEMBL18741877 0.79 GAA (0.49) GAAPDE2AKDM4EHTTRXFP1
Heptane SCHEMBL28836076 0.78 RARB (0.58) GAAKDM4EALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3424917-A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR Nippon Chemiphar Co., Ltd. (JP) 2019-01-09 EP disclosed
EP-2277874-B1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR NIPPON CHEMIPHAR CO (JP) 2018-06-27 EP disclosed
US-8648208-B2 Activating agent for peroxisome proliferator activated receptor NIPPON CHEMIPHAR CO. LTD. (JP) 2014-02-11 US disclosed
US-20110098480-A1 ACTIVATING AGENT FOR PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR NIPPON CHEMIPHAR CO. LTD. (JP) 2011-04-28 US disclosed
EP-2277874-A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR Nippon Chemiphar Co., Ltd. (JP) 2011-01-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110098480-A1 ACTIVATING AGENT FOR PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR PPARA, PPARG, PPARD GAA 3800/4885PDE2A 1843/4885KDM4E 3158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.